SEC 13F Intelligence

Ghost Tree Capital, LLC / ALLO

Ghost Tree Capital, LLC’s Allogene Therapeutics Inc Position

Does Ghost Tree Capital, LLC own Allogene Therapeutics Inc (ALLO)? Not currently — the last reported position was 150.0K shares worth $4M in Q3 2021; the fund’s latest 13F (Q3 2024) no longer reports it.

Position Value
$4M
Q3 2021
Shares
150.0K
% of Portfolio
+1.13%
Quarters Held
2
position exited

Position History ALLO

Reported value by quarter
Q2 ’21: $7MQ2 ’21Q3 ’21: $4MQ3 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2021150.0K$4M+1.13%
Q2 2021275.0K$7M+1.97%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ghost Tree Capital, LLC’s full portfolio or all institutional holders of ALLO.